November 21, 2019
Hyperbaric oxygen therapy (HBOT) is used to improve the supply of oxygen to damaged tissues, mainly due to oncological treatments. A group of researchers from Las Palmas, Spain, developed the protocol “FEASIBILITY OF A HYPERBARIC OXYGEN PROGRAM. TREATMENT OF TOXICITY. FIRST SPANISH EXPERIENCE “, to evaluate the viability, tolerability and short-term results of HBOT.
The patients were referred by several specialists and evaluated by a single doctor.
Each patient was administered a 60-minute daily session. In total, they received 40 sessions of hyperbaric oxygen therapy at 1.4 ATA (in BioBarica hyperbaric chambers). Patient characteristics and supportive treatment were recorded. Quality of Life surveys were conducted every 10 sessions.
Between February 2018 and January 2019, 31 patients were included:
With these results, it can be concluded that HBOT is a feasible and well-tolerated treatment. There is an improvement in the quality of life in the majority of treated patients.
Lloret M., Rivero J, Garcia L, Alonso D, Ferrandiz V, Lopez-Molina L, Cabrera R, Salas B, Ferrera L, Castilla-Martínez J, Kannemann A, Blanco J, Chicas-Sett R, Rodriguez-Melcón I , Federico M, Freitas-Ribeiro I, Cabezón MA, Rodriguez-Ibarria, Pinar B, Lara P.
Department of Radiation Oncology of the Dr. Negrín University Hospital of Gran Canaria. Las Palmas, Spain.
Undergraduate Faculty of Medicine, Las Palmas University of Gran Canaria. Las Palmas, Spain. Department of Oncology of San Roque University Hospital / Fernando Pessoa University Canarias. Las Palmas, Spain.